Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis

Norman Haughey, Veera V R Bandaru, Mihyun Bae, Mark P. Mattson

Research output: Contribution to journalArticle

Abstract

Sphingolipids in the membranes of neurons play important roles in signal transduction, either by modulating the localization and activation of membrane-associated receptors or by acting as precursors of bioactive lipid mediators. Activation of cytokine and neurotrophic factor receptors coupled to sphingomyelinases results in the generation of ceramides and gangliosides, which in turn, modify the structural and functional plasticity of neurons. In aging and neurodegenerative conditions such as Alzheimer's disease (AD), there are increased membrane-associated oxidative stress and excessive production and accumulation of ceramides. Studies of brain tissue samples from human subjects, and of experimental models of the diseases, suggest that perturbed sphingomyelin metabolism is a pivotal event in the dysfunction and degeneration of neurons that occurs in AD and HIV dementia. Dietary and pharmacological interventions that target sphingolipid metabolism should be pursued for the prevention and treatment of neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)878-886
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Volume1801
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Sphingolipids
Alzheimer Disease
Ceramides
Membranes
AIDS Dementia Complex
Nerve Growth Factor Receptors
Sphingomyelin Phosphodiesterase
Neurons
Nerve Degeneration
Sphingomyelins
Gangliosides
Neurodegenerative Diseases
Signal Transduction
Oxidative Stress
Theoretical Models
Pharmacology
Cytokines
Lipids
Brain

Keywords

  • Alzheimer's disease
  • Ceramide
  • Ganglioside
  • Sphingomylein
  • Sphingosine
  • Synapse

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. / Haughey, Norman; Bandaru, Veera V R; Bae, Mihyun; Mattson, Mark P.

In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1801, No. 8, 08.2010, p. 878-886.

Research output: Contribution to journalArticle

@article{002e021cdb3d467ba2def26c897fc6fd,
title = "Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis",
abstract = "Sphingolipids in the membranes of neurons play important roles in signal transduction, either by modulating the localization and activation of membrane-associated receptors or by acting as precursors of bioactive lipid mediators. Activation of cytokine and neurotrophic factor receptors coupled to sphingomyelinases results in the generation of ceramides and gangliosides, which in turn, modify the structural and functional plasticity of neurons. In aging and neurodegenerative conditions such as Alzheimer's disease (AD), there are increased membrane-associated oxidative stress and excessive production and accumulation of ceramides. Studies of brain tissue samples from human subjects, and of experimental models of the diseases, suggest that perturbed sphingomyelin metabolism is a pivotal event in the dysfunction and degeneration of neurons that occurs in AD and HIV dementia. Dietary and pharmacological interventions that target sphingolipid metabolism should be pursued for the prevention and treatment of neurodegenerative disorders.",
keywords = "Alzheimer's disease, Ceramide, Ganglioside, Sphingomylein, Sphingosine, Synapse",
author = "Norman Haughey and Bandaru, {Veera V R} and Mihyun Bae and Mattson, {Mark P.}",
year = "2010",
month = "8",
doi = "10.1016/j.bbalip.2010.05.003",
language = "English (US)",
volume = "1801",
pages = "878--886",
journal = "Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids",
issn = "1388-1981",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis

AU - Haughey, Norman

AU - Bandaru, Veera V R

AU - Bae, Mihyun

AU - Mattson, Mark P.

PY - 2010/8

Y1 - 2010/8

N2 - Sphingolipids in the membranes of neurons play important roles in signal transduction, either by modulating the localization and activation of membrane-associated receptors or by acting as precursors of bioactive lipid mediators. Activation of cytokine and neurotrophic factor receptors coupled to sphingomyelinases results in the generation of ceramides and gangliosides, which in turn, modify the structural and functional plasticity of neurons. In aging and neurodegenerative conditions such as Alzheimer's disease (AD), there are increased membrane-associated oxidative stress and excessive production and accumulation of ceramides. Studies of brain tissue samples from human subjects, and of experimental models of the diseases, suggest that perturbed sphingomyelin metabolism is a pivotal event in the dysfunction and degeneration of neurons that occurs in AD and HIV dementia. Dietary and pharmacological interventions that target sphingolipid metabolism should be pursued for the prevention and treatment of neurodegenerative disorders.

AB - Sphingolipids in the membranes of neurons play important roles in signal transduction, either by modulating the localization and activation of membrane-associated receptors or by acting as precursors of bioactive lipid mediators. Activation of cytokine and neurotrophic factor receptors coupled to sphingomyelinases results in the generation of ceramides and gangliosides, which in turn, modify the structural and functional plasticity of neurons. In aging and neurodegenerative conditions such as Alzheimer's disease (AD), there are increased membrane-associated oxidative stress and excessive production and accumulation of ceramides. Studies of brain tissue samples from human subjects, and of experimental models of the diseases, suggest that perturbed sphingomyelin metabolism is a pivotal event in the dysfunction and degeneration of neurons that occurs in AD and HIV dementia. Dietary and pharmacological interventions that target sphingolipid metabolism should be pursued for the prevention and treatment of neurodegenerative disorders.

KW - Alzheimer's disease

KW - Ceramide

KW - Ganglioside

KW - Sphingomylein

KW - Sphingosine

KW - Synapse

UR - http://www.scopus.com/inward/record.url?scp=77953268102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953268102&partnerID=8YFLogxK

U2 - 10.1016/j.bbalip.2010.05.003

DO - 10.1016/j.bbalip.2010.05.003

M3 - Article

VL - 1801

SP - 878

EP - 886

JO - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

JF - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

SN - 1388-1981

IS - 8

ER -